key: cord-0723981-sezheevu authors: Nguyen, N.; Lane, B.; Lee, S.; Gormon, S. L.; Wu, Y.; Li, A.; Lu, H.; Elhadad, N.; Yin, M.; Meyers, K. title: A Mixed Methods Study Evaluating Acceptability of a Daily COVID-19 Testing Regimen with a Mobile-App Connected, At-Home, Rapid Antigen Test: Implications for Current and Future Pandemics date: 2022-04-19 journal: nan DOI: 10.1101/2022.04.18.22273982 sha: 88e9defe7bfd621913444d4b8735f39ecf980757 doc_id: 723981 cord_uid: sezheevu Introduction. Widespread use of at-home rapid COVID-19 antigen tests has been proposed as an important public health intervention to interrupt chains of transmission. Antigen tests may be preferred over PCR because they provide on-demand results for relatively low cost and can identify people when they are most likely to be infectious, particularly when used daily. Yet the extent to which a frequent antigen testing intervention will result in a positive public health impact for COVID-19 will depend on high acceptability and high adherence to such regimens. Methods. We conducted a mixed-methods study assessing acceptability of and adherence to a daily at-home mobile-app connected rapid antigen testing regimen among employees of a US-based media company. Acceptability was assessed across seven domains of the Theoretical Framework of Acceptability. Results. Among 31 study participants, acceptability of the daily testing intervention was generally high, with participants reporting high perceived effectiveness, intervention coherence, and self-efficacy; positive affective attitude; acceptable degree of burden and opportunity cost; and assessing the intervention as ethical. 71% reported a preference to test daily using an at-home antigen test than weekly employment-based PCR. Mean adherence to the 21-day testing regimen was 88% with 43% of participants achieving 100% adherence, 48% testing at least every other day, and 10% testing less than every other day. Conclusions. Despite overall high acceptability and adherence, we identified three implementation challenges that must be addressed for frequent serial testing for COVID-19 to be implemented at scale and have a positive public health impact. First, users need guidance on how and when to adapt testing frequencies to different epidemiological conditions. Second, users and institutions need guidelines for how to safely store and share test results. Third, implementation of serial testing strategies must prioritize health equity and protect those most vulnerable to COVID-19. 82 Despite overall high acceptability and adherence, we identified three implementation challenges 83 that must be addressed for frequent serial testing for COVID-19 to be implemented at scale and 84 have a positive public health impact. First, users need guidance on how and when to adapt 85 testing frequencies to different epidemiological conditions. Second, users and institutions need 86 guidelines for how to safely store and share test results. Third, implementation of serial testing 87 strategies must prioritize health equity and protect those most vulnerable to COVID-19. 89 Key words: COVID-19, rapid antigen test, self-test, acceptability 90 91 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 19, 2022. ; https://doi.org/10.1101/2022.04.18.22273982 doi: medRxiv preprint 6 117 Yet the extent to which a massive influx of at-home antigen tests to the American public will result 118 in a positive public health impact will depend on whether and how the tests are used. To date, 119 there is limited real-world data on the acceptability of at-home antigen testing, particularly when 120 used serially, where they have been shown to be most effective. Previous implementation studies 121 of numerous evidence-based interventions, particularly those requiring sustained participation 122 and adherence, indicate that acceptability is critical to intervention uptake and success (13-15). 123 Even if at-home antigen tests become widely available, their public health impact will be limited if 124 frequent testing is not acceptable and adopted at scale. To address this knowledge gap, we 125 conducted a mixed-methods study informed by Sekhon's Theoretical Framework of Acceptability 126 (TFA) (16) to evaluate the acceptability of and adherence to a daily testing regimen among 127 employees of a large media company in the US. 132 We conducted a mixed-methods observational study from February-June 2021 to examine 133 factors that influenced the acceptability of and adherence to a serial testing regimen using a 134 self-administered at-home rapid antigen test ("at-home antigen test") in a workplace setting 135 among employees at two divisions of The Walt Disney Company ("Disney"), a media company 136 based in Southern California in the US. This mixed-methods acceptability study was nested 137 within a larger parent study (N=93) testing the effectiveness of a daily testing regimen using an 138 at-home antigen-test against weekly testing with PCR at Disney. Participants in the parent study 139 were mailed at-home COVID-19 antigen test kits to their home address and asked to self-test 140 daily for 21 days and, as a condition of their employment, were also concurrently testing at least 141 weekly for COVID-19 using PCR. In our nested acceptability study, after providing written 142 informed consent, participants were asked to complete a one-time quantitative survey (N=31), . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 184 Each of the TFA's seven constructs of acceptability was evaluated by one to three statements 185 which participants rated on a five-point Likert scale (strongly disagree=1 to strongly agree=5). 186 As a global measure of acceptability, participants were also asked whether, if given a choice, 187 they would prefer to test for COVID-19 using the current PCR regimen or test daily with an at-188 home antigen test. We measured sociodemographic factors, including age, race/ethnicity, sex, 189 education, living environment, and financial stability. Participants self-administered the 20-190 minute survey using REDCap, a secure web platform for administering online surveys. 193 We conducted in-depth interviews with participants to more deeply understand their current and 194 previous COVID-19 testing experiences and the acceptability of the daily COVID-19 testing . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 19, 2022. ; https://doi.org/10.1101/2022.04.18.22273982 doi: medRxiv preprint 211 range (IQR) for each TFA construct measure and also estimated the frequency and proportion 212 of participants who stated that they strongly agreed or agreed with each statement. We 213 calculated overall adherence by taking the number of submitted test results and dividing it by 214 the 21 days of the study. We categorized adherence into three groups and estimated the 215 number and proportion of participants per group: 100% (tested daily), 50%-99% (tested at least 216 every other day), and <50% (tested less than every other day). Finally, we calculated the 217 frequency and proportion of participants who stated they would prefer testing daily with a rapid 218 antigen test versus their current PCR regimen if given the choice. 219 220 2.5.2 Qualitative analysis . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 19, 2022. ; https://doi.org/10.1101/2022.04.18.22273982 doi: medRxiv preprint 10 221 Interview transcripts were analyzed by a team of three researchers in Dedoose using Template 222 Analysis, which is appropriate for studies using a priori themes and exploring perspectives of 223 different groups in an organizational context (17). We initiated data analysis with a top-down 224 approach, using the seven constructs in the TFA to create an organizational template. One 225 member of the research team created a preliminary codebook by reading through interview 226 debrief forms and identifying subconstructs within each of the TFA constructs. With the seven 227 TFA constructs listed as parent codes and the subconstructs as child codes, the initial codebook 228 was applied to two interview transcripts in Dedoose. A second researcher then applied the 229 preliminary codebook to two more interviews and the codebook was further discussed and 230 refined. All three coders then re-coded the initial four interviews using the finalized codebook to 231 maximize reliability across coders. The three coders then individually coded the remaining 11 232 interviews, meeting on an ad hoc basis to resolve coding questions, and using memos to note 233 emerging themes. The coders generated code reports for each TFA construct, identified key 234 quotes for each construct and subconstruct, and held team meetings to discuss emergent 235 themes that conceptualized how each construct either directly or indirectly influenced 236 acceptability and adherence. Lastly, we created quote matrices for each construct and 237 subconstruct using the identified key quotes organized by emergent themes. . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 19, 2022. 261 with the statement "I like using the test every day" (see Table 3 for mean and median Likert 262 scale scores). The overwhelming feeling reported by participants was comfort and peace of 263 mind (Table 4 , Affective attitude 1). Testing negative gave them needed reassurance to go 264 about their daily lives and participants reported feeling "liberated" to engage in everyday 265 activities without fear of infecting others (Affective attitude 2, 3). Participants also described 266 using the tests after engaging in a "high risk" activity or potentially being exposed to COVID-19 267 (Affective attitude 3). Notably, a small number of participants described significant anxiety due 268 to living with someone who was immunocompromised; for these participants, the ability to test 269 daily or on demand provided significant mental health benefits (Affective attitude 4). 271 For some participants who struggled to incorporate testing into their daily routine or who had 272 difficulty using the mobile app to capture and interpret their test result, daily testing was more . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 19, 2022. ; https://doi.org/10.1101/2022.04.18.22273982 doi: medRxiv preprint 12 273 burdensome. In these cases, participants reported feeling dread when they remembered they 274 still had to test or frustration at being repeatedly unable to scan in a test result through the 275 mobile app (Burden 6, Opportunity cost 5). 278 More than half of participants disagreed with the statements "it is inconvenient to use the self-279 test every day" (61%) ( Table 3 ). Most participants describing daily self-testing as very 280 convenient compared to other testing options they experienced (e.g., large drive-through testing 281 events early in March/April 2020 or mandatory testing offered by their employer). Even among 282 participants who had access to weekly on-site testing at their workplace, most preferred the 283 daily antigen test. These participants overwhelmingly described testing daily as fast and easy 284 often noting that daily self-testing took less time overall than weekly PCR testing (Table 4, 285 Burden 1); that they didn't mind daily testing because they could test on their own schedule and 286 get the results quickly (Burden 2) or incorporate self-testing into other established routines (e.g., 287 timing the 15-minute waiting period with a shower) (Burden 3); and that they did not find the 288 daily swabs to be invasive (Burden 4). While some participants described mild discomfort from 289 the daily swabbing, this was not a major burden. In the minority were participants who acknowledged that while daily at-home antigen testing was 292 more convenient than weekly PCR testing, they still preferred testing using PCR because of the 293 mental energy required to self-administer the test (Burden 5). Other participants described 294 difficulty incorporating testing into their daily routine and reported testing fatigue (Burden 6). 295 296 3.4.3 Self-efficacy 297 Participants reported that the self-test was easy to learn to use (90%) and results easy to 298 understand (100%) (Table 3) . However, only half of participants (55%) stated that they . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 19, 2022. ; https://doi.org/10.1101/2022.04.18.22273982 doi: medRxiv preprint 13 299 developed a habit of testing for COVID-19 in their daily routine, with experiences adhering to 300 daily testing varying widely across participants. While some participants reported feeling initially 301 overwhelmed by the testing steps, nearly all reported mastering the steps after a few days of 302 testing (Table 4 , Self-efficacy 1, 2). Factors that supported daily adherence included developing 303 strategies to streamline the testing process (Self-efficacy 2); incorporating the test into their 304 daily routine (Self-efficacy 3, 4); and placing the test kit in a prominent location (Self-efficacy 3). 305 In contrast, participants reported that changes to their daily routine and weekends were the 306 greatest barrier to daily adherence (Self-efficacy 5, 6). 309 Most participants strongly agreed with the statement: "It is easy for me to find a time to use the 310 test every day" (68%) (Table 3 ). Nonetheless, time was often described as the biggest 311 opportunity cost to testing daily (Table 4 , Opportunity cost 1, 2). Some participants attempted to 312 minimize the time cost by multi-tasking (Burden 3) or spreading out the time commitment by 313 setting up their test kit the night before (Self-efficacy 3). However, others reported that efforts to 314 multi-task resulted in more time spent testing because they would lead to mistakes like missing 315 the results window during and having to repeat the testing process again (Opportunity cost 1, 2, 316 3). For other participants, access to strong internet and/or a good light source were additional 317 opportunity costs to daily testing as the mobile app required a specific level of light to accurately 318 interpret the test result (Opportunity cost 4, 5). Participants who struggled to upload a picture of 319 their test result consequently described testing as a "daily hassle" and "frustrating", negatively 320 impacting their affective attitude about the testing regimen. 323 Most participants agreed that it is ethical for an employer to require its employees to test 324 regularly for COVID-19 (87%) (Table 3) . However, a small minority believed that regular testing . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 328 as a practical approach to keeping the workplace safe (Table 4, Ethicality 1, 2) . Specifically, 329 many used Utilitarian arguments to justify mandatory testing, saying that the small loss of 330 privacy and autonomy was justified for "the greater good" of workplace safety (Ethicality 3, 4, 5). 331 Others went further, stating that routine testing helped them fulfil their personal responsibility to 332 keep their workplace safe, noting that they "didn't want to be transmitters" and that giving 333 someone else COVID would be "an unacceptable thing" (Ethicality 6). In contrast, a small 348 contract tracing, surveillance, and allocation of health services (Ethicality 10); however, this 349 feeling was not universal, and some reported not trusting the CDC or worrying that the health 350 department would limit their freedom if they tested positive (Ethicality 11, 12) . Additionally, a . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 19, 2022. 369 While support for regular testing was near universal during times when risk of COVID-19 370 infection was perceived to be high (i.e., before vaccines were available, when rates of infection 371 were still increasing), there was less agreement about when routine testing was no longer 372 needed. Many participants thought it made sense to continue regular COVID-19 testing until 373 there was more research available on the transmissibility of emerging COVID-19 variants and 374 effectiveness of the COVID-19 vaccines (Coherence 5). Others preferred to listen to scientific 375 recommendations from public health agencies to decide whether frequent testing made sense 376 (Coherence 6). Some participants expressed increasing doubt that regular COVID-19 testing . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 19, 2022. ; https://doi.org/10.1101/2022.04.18.22273982 doi: medRxiv preprint 16 377 was still necessary given that vaccines were widely available to all adults and rates of COVID-378 19 in the workplace and surrounding community were very low (Figure 1) . One participant in a 379 managerial position used a cost benefit analysis to argue that frequent testing did not make 380 sense from a financial perspective given the low positivity rates (Coherence 7). Many believed 381 testing did not make sense for vaccinated populations, but that it may be an alternative for those 382 who did not wish to become vaccinated (Coherence 8). 385 Participants had high confidence in the effectiveness of a daily testing intervention with the 386 majority reporting that they trusted the results of the at-home antigen test (81%) and nearly all 387 expressing confidence that testing daily will keep the people they work with safe from COVID-19 388 (90%) ( Table 3) . Whether participants perceived the daily testing intervention would keep the 389 workplace safe depended on three factors: 1) whether they trusted the test results, 2) whether 390 they believed their co-workers would be willing and able to test daily, and 3) whether they 391 believed frequent testing would introduce any unintended consequences. Although the antigen 392 test used in the study had not yet received FDA approval and was only for use in research 393 settings, nearly all participants reported trusting the results, citing trust in Columbia University 394 (which helped develop the test in collaboration with a biotechnology company), trust in Disney 395 (their employer) to provide a safe and effective test, and trust in experts/scientists (Table 4, 396 Perceived effectiveness 1, 2). Other participants drew on previous experience using similar at-397 home tests (e.g., home pregnancy tests, glucose monitoring, maintaining swimming pool pH) as 398 reasons for trusting the results (Perceived effectiveness 3). One participant noted that they 399 trusted the daily antigen test result more than weekly PCR because the antigen test result 400 reflected current COVID-19 status while the PCR result reflected a status from 24-48 hours ago 401 and could give a false sense of security (Perceived effectiveness 4). In contrast, a different 402 participant reported trusting the antigen test result less than PCR because they had heard from . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 19, 2022. 406 While participants were generally confident in their own ability to successfully use the at-home 407 antigen test, they were less confident about their co-workers' abilities, which they believed could 408 undermine the effectiveness of the daily testing intervention. These concerns included not 409 believing that their coworkers would obtain a sufficient swab sample and properly self- 424 responded with significant resources to rapidly increase the availability of antigen tests in the 425 US beginning late January 2022. The extent to which this intervention will have a significant 426 public health impact remains to be seen but will in part depend on whether, and if so, how, 427 Americans will use these tests. However as of January 2022, to our knowledge no studies have . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 19, 2022. ; https://doi.org/10.1101/2022.04.18.22273982 doi: medRxiv preprint 18 428 examined the acceptability of self-testing for COVID-19, including serial testing regimens that 429 have been shown most effective at detecting cases. Our mixed-methods study on the acceptability of a serial testing regimen showed that daily 432 testing using an at-home antigen COVID-19 test was acceptable in one employment context. 433 Employees were willing and able to adhere to a daily testing regimen for up to 21 days, with 434 75% of participants achieving adherence 90% or greater. In addition to reporting overall high 435 acceptability and adherence, our study identified three key implementation challenges that must 436 be addressed for antigen tests to reach their full public health potential. 438 First, there is a significant need for educational campaigns to build lay user trust in the accuracy 439 of at-home antigen tests and knowledge around when and how to use them, including how to 440 act on test results (26). Of the seven constructs that comprise acceptability, coherence and 441 perceived effectiveness were most salient and determined whether participants ultimately felt it 442 "was worth it" to test for COVID-19 daily. Importantly with respect to coherence, participants 443 expressed a willingness to tolerate burden (inconvenience, invasiveness), opportunity costs 444 (time), threats to ethicality (loss of privacy) associated with daily testing when they perceived the 445 threat of COVID-19 to be high (high coherence), but indicated that given testing fatigue, this 446 tolerance would not last forever. In the face of declining cases and universal access to 447 vaccination among adults, participants saw a time in the then near future when this testing 448 frequency would no longer be necessary, rendering the intervention less acceptable. As shown 449 in Figure 1 , the study was implemented right before the emergence of the Delta variant when 450 case numbers were decreasing, vaccination eligibility was extended to study participants, and 451 the fear of COVID was palpably receding in the public domain and among our study 452 participants. Respondents reported that daily at-home testing made less sense at this moment 453 in the epidemic than it had one month earlier when case numbers were rising and vaccinations . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 19, 2022. 476 Second, we wish to highlight that any frequent testing campaign will generate an enormous 477 amount of sensitive health data and there is currently no existing universal infrastructure for 478 routinely capturing or reporting this information to relevant health authorities, health care 479 providers, or institutions (e.g., employers, schools). The lack of a universal recording and . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) (34-36) ; 2) sharing of COVID-19 test results through non-484 secure channels (e.g., text messages, emails) providing opportunities for privacy breaches (37-485 39); and 3) challenges for the delivery of anti-viral treatments for COVID-19 within three days 486 after symptom-onset for maximum benefit, due to the lack of guidance on whether a positive 487 home antigen test can be used to qualify for treatment (40,41). In our study, testing data was 488 captured securely and systematically using a mobile app that recorded and interpreted the test 489 result for the user; these data were only shared with the study team, but the app could be 490 further developed to support secure sharing with other entities. Most participants in our study 491 found the app to be acceptable, however using this app was not without challenges, and some 492 participants experienced significant difficulty using the app daily due to lack of internet or smart 493 phone operating system too old to support the app. In a less technology savvy population, 494 comfort with smart phone technology may also be a significant barrier. Further, while nearly all 495 participants were comfortable with tests results being shared with the research team and their 496 employer, they expressed significant concern about results being shared with health or 497 government entities aside from their own provider. 499 Anticipating potentially more dangerous pandemics in the near future, the Biden administration 500 has developed a five-pillar plan for pandemic preparedness that includes "transforming our 501 medical defense [through] dramatically improving diagnostics" (Pillar 1) and "ensuring situational 502 awareness about infectious disease threats for both early warning and real-time monitoring" 503 (Pillar 2) (42). A connected at-home antigen test that could accurately capture tests results and 504 share them with government and health authorities in real time would address both pillars, 505 however significant work remains to be done to build public trust and acceptability in such a . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 19, 2022. ; https://doi.org/10.1101/2022.04.18.22273982 doi: medRxiv preprint 21 506 system (43). Within the current pandemic, anecdotally, antigen test results are already being 507 informally shared with institutions like schools and employers to support strategies like "test to 508 stay" (testing to remain after exposure) and "test to return" (testing to end isolation or return 509 after infection). To our knowledge, there has been little to no research done on how these 510 results are currently being shared or stored; guidelines for best practices are urgently needed. 512 Finally third, given that the COVID-19 and future pandemics may disproportionally and 513 negatively affect low-income and marginalized communities, it is essential that serial testing 514 interventions in the workplace and elsewhere be employed in ways that put equity at the 515 forefront. Mandatory workplace testing policies have the potential to both protect the most 516 vulnerable, front-line employees, but if instituted without proper protections, can also create 517 negative unintended consequences that may disproportionately burden vulnerable populations. 518 The acceptability of a daily testing regimen in this study population was likely influenced by the 519 employment context, including already established norms around routine COVID-19 testing, and 520 job security and benefits (e.g., health insurance, dedicated paid COVID-19 sick leave) available 521 to participants in our study who were all employed full-time. Although we anticipated and probed 522 for worries about job security or loss of income due to testing positive for COVID-19, 523 hypothesizing that this could reduce acceptability and adherence to the intervention, no 524 participants reported such concerns. Possibly because of their job security, participants also 525 almost universally believed that mandatory COVID-19 testing in the workplace was ethical. In 526 other employment contexts with less job and income protection, mandatory serial testing may 527 be much less acceptable and could have harmful unintended consequences. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted April 19, 2022. ; https://doi.org/10.1101/2022.04.18.22273982 doi: medRxiv preprint 22 531 Our study contributed to the knowledge gap around the implementation of serial at-home rapid 532 antigen testing regimens. This is the first study to our knowledge to evaluate the acceptability of 533 a serial COVID-19 testing regimen with a connected test in an employment context and report 534 on adherence to the intervention. Our study advanced the Theoretical Framework of 535 Acceptability by developing quantitative measures of acceptability and identifying three critical 536 barriers to the successful implementation of rapid antigen testing as a public health intervention. 538 There were also a number of limitations. The study was implemented at a time of relatively low 539 COVID worry as the number of cases was falling steeply and vaccines offered a promise of 540 durable protection. This epidemiological context along with the COVID-19 vaccine exclusion 541 criterion impacted our ability to enroll a larger number of study participants and limits the 542 generalizability of the findings and our ability to reach saturation. However, low accrual 543 highlighted that context is an understudied component of acceptability causing acceptability to 544 vary across time. Generalizability may also be limited by the fact that the small study was 545 conducted in Southern California in a politically liberal area with high support for COVID 546 precautions and within a stable employment context. Participants were all fully employed at a 547 large company (Disney), and race, education, and SES are not representative of the broader 548 US population. The relatively high adherence to the intervention we report is likely an artifact of 549 the study context and selection bias based on willingness to enroll in the parent daily testing 550 study and participate in in-depth interviews about the experience; we would expect adherence 551 to be lower in the real world. Finally, we only looked at serial testing in an employment setting, 552 although serial testing has now been rolled out in other contexts. Additional studies are needed 553 to build the evidence-base about the acceptability of and adherence to serial-testing regimens to 554 evaluate their public health contribution to interrupting transmission. 555 556 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) Interviews were approximately 60 minutes long and conducted over Zoom by a team of four 197 researchers experienced in qualitative interviewing White cis-gendered male; all four lived in New York City. All four were employed by Columbia University, which made rapid turnaround PCR testing available as needed in addition to random 201 surveillance testing, and all were also using at-home antigen tests in their personal lives Interviews were summarized in debrief forms immediately after completing the interviews and 203 were audiorecorded and transcribed by a paid transcription service We summarized participant characteristics by estimating mean, standard deviation, frequency 209 and proportion for all categorical and continuous sociodemographic and health factor variables, 210 respectively. Additionally, we estimated the mean, standard deviation, median Put to the test: use of rapid testing technologies 587 for covid-19 Order coronavirus (COVID-19) rapid lateral flow tests The White House. Fact Sheet: The Biden Administration to Begin Distributing At-Home Rapid COVID-19 Tests to Americans for Free Press Briefing by White House COVID-19 Response Team and Public 596 Health Officials The White House. President Biden's COVID-19 Plan Managing Clinical Knowledge for Health Care Improvement Basic research and health: a reassessment of the scientific 604 basis for the support of biomedical science The answer is 17 years, what is the question: 608 understanding time lags in translational research Acceptability of healthcare interventions: An 611 overview of reviews and development of a theoretical framework King N. Doing Template Analysis. Qual Organ Res Core Methods Curr Challenges Rapid 616 epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa Clinical outcomes 619 among patients infected with Omicron (B.1.1.529) SARS-CoV-2 variant in southern SARS-CoV-2 Omicron Variant 623 Neutralization in Serum from Vaccinated and Convalescent Persons Omicron 626 extensively but incompletely escapes Pfizer BNT162b2 neutralization Mapping the antigenic diversification of SARS-CoV-2. MedRxiv Prepr Emergence and 633 expansion of SARS-CoV-2 B.1.526 after identification in New York International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity COVID-19 risk perception: a longitudinal analysis of its predictors and associations with 637 health protective behaviours in the United Kingdom Exploring the dynamic 641 relationships between risk perception and behavior in response to the Coronavirus 642 Disease 2019 (COVID-19) outbreak Assessing How Consumers Interpret 645 and Act on Results From At-Home COVID-19 Self-test Kits: A Randomized Clinical Trial Diagnostics for COVID-19: moving from 649 pandemic response to control Discordant SARS-CoV-2 PCR and Rapid 653 Antigen Test Results When Infectious: A December 2021 Occupational Case Series Direct 657 Comparison of SARS-CoV-2 Nasal RT-PCR and Rapid Antigen Test Community Testing Site During an Omicron Surge the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted Omicron Variant: Impact on Antigen Diagnostic Tests (As of 12/28/2021) Analytical 666 sensitivity of seven SARS-CoV-2 antigen-detecting rapid tests for Omicron variant Saliva swabs are the 670 preferred sample for Omicron detection Spatial Inequities in COVID-19 Testing Confirmed Cases, and Mortality in 3 U.S. Cities : An Ecological Study. Ann 675 Intern Med Growing use of home COVID-19 tests leaves health agencies in the dark 677 about unreported cases At-Home Covid Tests Raise Questions About Accurately Counting Cases 681 At-Home 684 the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted Evaluating the Privacy of Covid-19 At-Home Tests Equal Employment Opportunity Commission. What You Should Know About COVID-691 19 and the ADA, the Rehabilitation Act, and Other EEO Laws Towards a new era of mass data 695 collection: Assessing pandemic surveillance technologies to preserve user privacy Test and treat: a missing link in the global 701 fight against COVID-19 American Pandemic Preparedness: Transforming Our Capabilities Target Product Profile for 707 a mobile app to read rapid diagnostic tests to strengthen infectious disease surveillance